Suppr超能文献

普通变异性免疫缺陷患者对 TLR9 配体(CpG-ODN)、肺炎链球菌和流感嗜血杆菌提取物的 B 细胞反应缺陷。

Defective B cell response to TLR9 ligand (CpG-ODN), Streptococcus pneumoniae and Haemophilus influenzae extracts in common variable immunodeficiency patients.

机构信息

Servei d'Immunologia, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS), Hospital Son Dureta, Palma de Mallorca, Spain.

出版信息

Cell Immunol. 2010;262(2):105-11. doi: 10.1016/j.cellimm.2010.01.002. Epub 2010 Jan 25.

Abstract

Common variable immunodeficiency (CVID) is a primary immunodeficiency characterized by hypogammaglobulinaemia and antibody deficiency to both T dependent and independent antigens. Patients suffer from recurrent sinopulmonary infections mostly caused by Streptococcus pneumoniae and Haemophilus influenzae, but also gastrointestinal or autoimmune symptoms. Their response to vaccination is poor or absent. In this study we investigated B cell activation induced by the TLR9 specific ligand (CpG-ODN) and bacterial extracts from S. pneumoniae and H. influenzae known to stimulate several TLR. We found that B cells from CVID patients express lower levels of CD86 after stimulation with CpG-ODN, S. pneumoniae and H. influenzae extracts in combination with anti-IgM antibody and also display a lower proliferative index when stimulated with bacterial extracts. Our results point to a broad TLR signalling defect in B lymphocytes from CVID patients that may be related to the hypogammaglobulinaemia and poor response to vaccination characteristic of these patients.

摘要

普通变异性免疫缺陷症(CVID)是一种原发性免疫缺陷症,其特征是低丙种球蛋白血症和对 T 依赖性和非依赖性抗原的抗体缺陷。患者易反复发作肺炎和鼻窦感染,多由肺炎链球菌和流感嗜血杆菌引起,但也可能出现胃肠道或自身免疫症状。他们对疫苗的反应不佳或缺失。在本研究中,我们研究了 TLR9 特异性配体(CpG-ODN)和已知能刺激多种 TLR 的肺炎链球菌和流感嗜血杆菌细菌提取物诱导的 B 细胞激活。我们发现,CpG-ODN、肺炎链球菌和流感嗜血杆菌提取物与抗 IgM 抗体联合刺激后,CVID 患者的 B 细胞表达的 CD86 水平较低,而且当受到细菌提取物刺激时,增殖指数也较低。我们的结果表明,CVID 患者的 B 淋巴细胞存在广泛的 TLR 信号转导缺陷,这可能与这些患者的低丙种球蛋白血症和对疫苗接种的反应不佳有关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验